China · Delayed Price · Currency is CNY Byhealth Statistics
Total Valuation
Byhealth has a market cap or net worth of CNY 16.65 billion. The enterprise value is 12.62 billion.
| Market Cap | 16.65B |
| Enterprise Value | 12.62B |
Important Dates
The last earnings date was Saturday, October 24, 2026.
| Earnings Date | Oct 24, 2026 |
| Ex-Dividend Date | Apr 21, 2026 |
Share Statistics
Byhealth has 1.68 billion shares outstanding. The number of shares has decreased by -4.32% in one year.
| Current Share Class | 1.68B |
| Shares Outstanding | 1.68B |
| Shares Change (YoY) | -4.32% |
| Shares Change (QoQ) | +3.10% |
| Owned by Insiders (%) | 45.31% |
| Owned by Institutions (%) | 9.31% |
| Float | 916.14M |
Valuation Ratios
The trailing PE ratio is 23.86 and the forward PE ratio is 23.76.
| PE Ratio | 23.86 |
| Forward PE | 23.76 |
| PS Ratio | 2.48 |
| PB Ratio | 1.48 |
| P/TBV Ratio | 1.73 |
| P/FCF Ratio | 35.12 |
| P/OCF Ratio | 27.91 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.68, with an EV/FCF ratio of 26.55.
| EV / Earnings | 18.14 |
| EV / Sales | 1.88 |
| EV / EBITDA | 11.68 |
| EV / EBIT | 15.91 |
| EV / FCF | 26.55 |
Financial Position
The company has a current ratio of 3.18, with a Debt / Equity ratio of 0.11.
| Current Ratio | 3.18 |
| Quick Ratio | 2.50 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | 1.11 |
| Debt / FCF | 2.52 |
| Interest Coverage | 75.03 |
Financial Efficiency
Return on equity (ROE) is 6.20% and return on invested capital (ROIC) is 9.57%.
| Return on Equity (ROE) | 6.20% |
| Return on Assets (ROA) | 3.54% |
| Return on Invested Capital (ROIC) | 9.57% |
| Return on Capital Employed (ROCE) | 6.92% |
| Weighted Average Cost of Capital (WACC) | 5.95% |
| Revenue Per Employee | 2.32M |
| Profits Per Employee | 239,824 |
| Employee Count | 2,867 |
| Asset Turnover | 0.48 |
| Inventory Turnover | 3.03 |
Taxes
In the past 12 months, Byhealth has paid 178.47 million in taxes.
| Income Tax | 178.47M |
| Effective Tax Rate | 20.34% |
Stock Price Statistics
The stock price has decreased by -20.31% in the last 52 weeks. The beta is 0.38, so Byhealth's price volatility has been lower than the market average.
| Beta (5Y) | 0.38 |
| 52-Week Price Change | -20.31% |
| 50-Day Moving Average | 9.62 |
| 200-Day Moving Average | 10.55 |
| Relative Strength Index (RSI) | 61.01 |
| Average Volume (20 Days) | 10,175,609 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Byhealth had revenue of CNY 6.65 billion and earned 687.58 million in profits. Earnings per share was 0.42.
| Revenue | 6.65B |
| Gross Profit | 4.56B |
| Operating Income | 783.93M |
| Pretax Income | 877.57M |
| Net Income | 687.58M |
| EBITDA | 1.07B |
| EBIT | 783.93M |
| Earnings Per Share (EPS) | 0.42 |
Balance Sheet
The company has 5.28 billion in cash and 1.18 billion in debt, with a net cash position of 4.10 billion or 2.45 per share.
| Cash & Cash Equivalents | 5.28B |
| Total Debt | 1.18B |
| Net Cash | 4.10B |
| Net Cash Per Share | 2.45 |
| Equity (Book Value) | 11.15B |
| Book Value Per Share | 6.62 |
| Working Capital | 5.16B |
Cash Flow
In the last 12 months, operating cash flow was 591.13 million and capital expenditures -121.37 million, giving a free cash flow of 469.76 million.
| Operating Cash Flow | 591.13M |
| Capital Expenditures | -121.37M |
| Depreciation & Amortization | 282.53M |
| Net Borrowing | 89.54M |
| Free Cash Flow | 469.76M |
| FCF Per Share | 0.28 |
Margins
Gross margin is 68.65%, with operating and profit margins of 11.79% and 10.34%.
| Gross Margin | 68.65% |
| Operating Margin | 11.79% |
| Pretax Margin | 13.20% |
| Profit Margin | 10.34% |
| EBITDA Margin | 16.04% |
| EBIT Margin | 11.79% |
| FCF Margin | 7.07% |
Dividends & Yields
This stock pays an annual dividend of 0.45, which amounts to a dividend yield of 4.53%.
| Dividend Per Share | 0.45 |
| Dividend Yield | 4.53% |
| Dividend Growth (YoY) | 25.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 109.96% |
| FCF Payout Ratio | 119.99% |
| Buyback Yield | 4.32% |
| Shareholder Yield | 8.88% |
| Earnings Yield | 4.19% |
| FCF Yield | 2.85% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for Byhealth is 11.43, which is 14.99% higher than the current price. The consensus rating is "Buy".
| Price Target | 11.43 |
| Price Target Difference | 14.99% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 10.43% |
| EPS Growth Forecast (3Y) | 17.56% |
Stock Splits
The last stock split was on April 1, 2016. It was a forward split with a ratio of 2.
| Last Split Date | Apr 1, 2016 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
Byhealth has an Altman Z-Score of 5.86 and a Piotroski F-Score of 7.
| Altman Z-Score | 5.86 |
| Piotroski F-Score | 7 |